Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Quant Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Anne Forst, April Eichler, Beth Overmoyer, Nancy U. Lin, Wendy Y. Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo-Jack, Michael D. White, Jorg Dietrich, Naema Nayyar, Albert E. Kim, Christopher Alvarez-Breckenridge, Maura Mahar, Joana L. Mora, Brian V. Nahed, Pamela S. Jones, Helen A. Shih, Elizabeth R. Gerstner, Anita Giobbie-Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan
Ձևաչափ:	Հոդված
Լեզու:	English
Հրապարակվել է:	Nature Portfolio 2021-10-01
Շարք:	Nature Communications
Առցանց հասանելիություն:	https://doi.org/10.1038/s41467-021-25859-y

Համացանց

https://doi.org/10.1038/s41467-021-25859-y